Sleep Apnea Therapy
Establishing

Establishing effective
sleep apnea therapy

The benefits of positive airway pressure (PAP) therapy to the sleep apnea patient have been well documented. Unfortunately, many people have difficulty accepting or adapting to therapy because treatment can seem overwhelming, complex and uncomfortable. That, in turn, can complicate things for the provider.
 

Working closely with customers and their patients, we’re developing sleep apnea therapy solutions that not only achieve clinical efficacy and streamline care, but are designed to be inviting to use night after night so patients can enjoy better days.

 

Get more information about Philips Respironics sleep apnea therapy solutions.

*

Contact information

* This field is mandatory

*
*
*
*
*
*
*
*
*

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Final CEE consent

Untreated sleep apnea can result in a range of health issues

Untreated sleep apnea can result in a range of health issues

Supporting Sleep Apnea Patients

biggest loser sleep apnea video

“You’ll love the fact that you’re feeling rested and have the energy to get through the day.”

 

Ashley Johnston, The Biggest Loser

identifying sleep apnea therapy issues

Discomfort, issues related to the bed partner, and travel are common sleep apnea therapy roadblocks.

sleepmapper therapy management system

Mobile and web-based systems may help patients embrace sleep apnea therapy.

patient testimonial video

A patient talks about his experience with our Wisp miniaml contact nasal mask.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.